Pathologic characteristics of digestive tract and liver in patients with coronavirus disease 2019

C Yang, L Cai, SY Xiao - Gastroenterology Clinics, 2023 - gastro.theclinics.com
With the high prevalence of coronavirus disease-2019 (COVID-19), there has been
increasing understanding of the pathologic changes associated with the severe acute …

Evaluation of pathological findings of COVID-19 by minimally invasive autopsies: a single tertiary care center experience from India

V Vishwajeet, A Purohit, D Kumar… - Journal of …, 2021 - thieme-connect.com
Objectives The 2019 novel coronavirus (2019-nCoV) has spread across the globe with more
than 6 lakh deaths. Clinical autopsies are important to understand the pathobiology of the …

[HTML][HTML] COVID-19 and inflammatory bowel disease: A pathophysiological assessment

C Yang, SY Xiao - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, has led to the
ongoing global pandemic. Although most patients experience no or only mild symptoms …

COVID-19 patients with hepatic complications during the third wave of pandemic in Egypt

AM Fahmy, MO Elgendy, AM Khalaf… - Journal of Clinical …, 2022 - ojs.bbwpublisher.com
COVID-19 is a respiratory infection that has lately begun to affect other vital organs,
including the heart, kidney, and liver. The purpose of this study was to investigate the …

[HTML][HTML] Liver and COVID-19: From care of patients with liver diseases to liver injury

R Gaspar, CC Branco, G Macedo - World journal of hepatology, 2021 - ncbi.nlm.nih.gov
The global pandemic of coronavirus disease 2019 (COVID-19) changed dramatically all
priorities on medical society and created several challenges for clinicians caring for patients …

[HTML][HTML] Patterns of liver profile disturbance in patients with COVID-19

HI Shousha, A Ramadan, R Lithy… - World Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Fever and cough are the most common clinical symptoms of coronavirus disease 2019
(COVID-19), but complications (such as pneumonia, respiratory distress syndrome, and …

[HTML][HTML] Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections

UN Das - Archives of medical science: AMS, 2023 - ncbi.nlm.nih.gov
COVID-19 is caused by SARS-CoV-2 infection. Epithelial and T, NK, and other immunocytes
release bioactive lipids especially arachidonic acid (AA) in response to microbial infections …

An adverse outcomes approach to study the effects of SARS-CoV-2 in 3D organoid models

A Basu, A Pamreddy, P Singh, K Sharma - Journal of Molecular Biology, 2022 - Elsevier
The novel SARS-CoV-2 virus outbreak is the major cause of a respiratory disease known as
COVID-19. It has caused a global pandemic and has resulted in mortality in millions. The …

COVID-19 and liver damage: narrative review and proposed clinical protocol for critically ill pediatric patients

M Luglio, U Tannuri, WB de Carvalho, KLM Bastos… - Clinics, 2020 - SciELO Brasil
SARS-CoV-2 shares nearly 80% of its' genomic sequence with SARS-CoV and MERS-CoV,
both viruses known to cause respiratory symptoms and liver impairment. The emergence of …

[HTML][HTML] Effects of COVID-19 on the liver: The experience of a single center

V Liakina, I Stundiene, G Milaknyte… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND The coronavirus disease 2019 (COVID-19) was perhaps the most severe
global health crisis in living memory. Alongside respiratory symptoms, elevated liver …